Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Michael Behrens

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Personalized Medicine|November 27, 2021
Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric CancerAnne Hoffmann, Hans-Michael Behrens, Steffen Heckl, et al.
Molecular Cancer Research : MCR|February 22, 2017
Novel Insights into Gastric Cancer: Methylation of R-spondins and Regulation of LGR5 by SP1Franziska Wilhelm, Eva Simon, Christine Böger, et al.
Virchows Archiv : an International Journal of Pathology|February 26, 2016
Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patientsSophie Freudenthaler, Ute Hegenbart, Stefan Schönland, et al.
The American Journal of Pathology|March 26, 2011
Genotypic and phenotypic characterization of side population of gastric cancer cell linesRosa Schmuck, Viktoria Warneke, Hans-Michael Behrens, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 1, 2021
Complement 9 in amyloid depositsAnnelie Lux, Juliane Gottwald, Hans-Michael Behrens, et al.
Human Pathology|September 24, 2020
p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohortIsabelle Schoop, Saffiyeh Saboor Maleki, Hans-Michael Behrens, et al.
Histopathology|June 3, 2015
MET in gastric cancer--discarding a 10% cutoff ruleMarie-Luise Metzger, Hans-Michael Behrens, Christine Böger, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2019
The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implicationsSteffen M Heckl, Viva Wiesener, Hans-Michael Behrens, et al.
BMC Cancer|July 31, 2020
Questioning the IGF1 receptor's assigned role in CRC - a case for rehabilitation?Steffen M Heckl, Marie Pellinghaus, Hans-Michael Behrens, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 28, 2023
The putative pleiotropic functions of meprin β in gastric cancerWiebke Siemsen, Christine Halske, Hans-Michael Behrens, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Personalized Medicine|November 27, 2021
Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric CancerAnne Hoffmann, Hans-Michael Behrens, Steffen Heckl, et al.
Molecular Cancer Research : MCR|February 22, 2017
Novel Insights into Gastric Cancer: Methylation of R-spondins and Regulation of LGR5 by SP1Franziska Wilhelm, Eva Simon, Christine Böger, et al.
Virchows Archiv : an International Journal of Pathology|February 26, 2016
Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patientsSophie Freudenthaler, Ute Hegenbart, Stefan Schönland, et al.
The American Journal of Pathology|March 26, 2011
Genotypic and phenotypic characterization of side population of gastric cancer cell linesRosa Schmuck, Viktoria Warneke, Hans-Michael Behrens, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 1, 2021
Complement 9 in amyloid depositsAnnelie Lux, Juliane Gottwald, Hans-Michael Behrens, et al.
Human Pathology|September 24, 2020
p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohortIsabelle Schoop, Saffiyeh Saboor Maleki, Hans-Michael Behrens, et al.
Histopathology|June 3, 2015
MET in gastric cancer--discarding a 10% cutoff ruleMarie-Luise Metzger, Hans-Michael Behrens, Christine Böger, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2019
The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implicationsSteffen M Heckl, Viva Wiesener, Hans-Michael Behrens, et al.
BMC Cancer|July 31, 2020
Questioning the IGF1 receptor's assigned role in CRC - a case for rehabilitation?Steffen M Heckl, Marie Pellinghaus, Hans-Michael Behrens, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 28, 2023
The putative pleiotropic functions of meprin β in gastric cancerWiebke Siemsen, Christine Halske, Hans-Michael Behrens, et al.
Pageof 7